Preventing venous thromboembolism in cancer patients: can we do better?
作者信息
Lyman Gary H
出版信息
J Oncol Pract. 2009 Jul;5(4):165-6. doi: 10.1200/JOP.0941501.
Abstract
摘要
相似文献
1
Preventing venous thromboembolism in cancer patients: can we do better?预防癌症患者的静脉血栓栓塞：我们能做得更好吗？
J Oncol Pract. 2009 Jul;5(4):165-6. doi: 10.1200/JOP.0941501.
2
Low-molecular-weight heparins for the prevention of recurrent venous thromboembolism in patients with cancer: A systematic literature review of efficacy and cost-effectiveness.低分子量肝素用于预防癌症患者复发性静脉血栓栓塞：疗效和成本效益的系统文献综述
J Oncol Pharm Pract. 2019 Jan;25(1):68-75. doi: 10.1177/1078155217727140. Epub 2017 Aug 31.
3
The role of low-molecular-weight heparins in the prevention and treatment of venous thromboembolism in cancer patients.低分子量肝素在癌症患者静脉血栓栓塞预防和治疗中的作用。
Curr Opin Pulm Med. 2003 Sep;9(5):351-5. doi: 10.1097/00063198-200309000-00002.
4
Low-dose aspirin for preventing recurrent venous thromboembolism.低剂量阿司匹林预防静脉血栓栓塞复发。
N Engl J Med. 2012 Nov 22;367(21):1979-87. doi: 10.1056/NEJMoa1210384. Epub 2012 Nov 4.
5
Aspirin for preventing the recurrence of venous thromboembolism.阿司匹林预防静脉血栓栓塞复发。
N Engl J Med. 2012 May 24;366(21):1959-67. doi: 10.1056/NEJMoa1114238.
6
Prevention of venous thromboembolism in patients with spinal cord injury: effects of sequential pneumatic compression and heparin.脊髓损伤患者静脉血栓栓塞的预防：序贯气压式压迫和肝素的作用
J Spinal Cord Med. 1999 Fall;22(3):182-91. doi: 10.1080/10790268.1999.11719568.
7
Update on extended treatment for venous thromboembolism.静脉血栓栓塞症的延长治疗进展。
Ann Med. 2018 Dec;50(8):666-674. doi: 10.1080/07853890.2018.1538564. Epub 2018 Dec 29.
8
The Impact of ABO Blood Type on Developing Venous Thromboembolism in Cancer Patients: Systematic Review and Meta-Analysis.ABO血型对癌症患者发生静脉血栓栓塞的影响：系统评价与荟萃分析
J Clin Med. 2021 Aug 20;10(16):3692. doi: 10.3390/jcm10163692.
9
Incidence of venous thromboembolism in patients hospitalized with cancer.癌症住院患者静脉血栓栓塞的发生率。
Am J Med. 2006 Jan;119(1):60-8. doi: 10.1016/j.amjmed.2005.06.058.
10
Compliance with recommendations of clinical practice in the management of venous thromboembolism in cancer: the CARMEN study.癌症患者静脉血栓栓塞管理中临床实践建议的依从性：CARMEN研究
J Mal Vasc. 2014 May;39(3):161-8. doi: 10.1016/j.jmv.2014.03.001. Epub 2014 Apr 18.
引用本文的文献
1
A Prospective Observational Study to Determine Rate of Thromboprophylaxis in Oncology Patients Undergoing Abdominal or Pelvic Surgery.一项前瞻性观察性研究，以确定接受腹部或盆腔手术的肿瘤患者的血栓预防率。
Indian J Surg Oncol. 2021 Jun;12(2):279-285. doi: 10.1007/s13193-021-01281-0. Epub 2021 Mar 1.
本文引用的文献
1
Are There Any Differences in the Clinical and Economic Outcomes Between US Cancer Patients Receiving Appropriate or Inappropriate Venous Thromboembolism Prophylaxis?美国接受适当或不适当静脉血栓栓塞预防的癌症患者在临床和经济结局方面是否存在差异？
J Oncol Pract. 2009 Jul;5(4):159-64. doi: 10.1200/JOP.0942002.
2
Development and validation of a predictive model for chemotherapy-associated thrombosis.化疗相关性血栓形成预测模型的开发与验证
Blood. 2008 May 15;111(10):4902-7. doi: 10.1182/blood-2007-10-116327. Epub 2008 Jan 23.
3
American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer.美国临床肿瘤学会指南：癌症患者静脉血栓栓塞预防和治疗的建议
J Clin Oncol. 2007 Dec 1;25(34):5490-505. doi: 10.1200/JCO.2007.14.1283. Epub 2007 Oct 29.
4
Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients.住院癌症患者静脉血栓栓塞的发生率、危险因素及趋势
Cancer. 2007 Nov 15;110(10):2339-46. doi: 10.1002/cncr.23062.
5
Thromboprophylaxis rates in US medical centers: success or failure?美国医疗中心的血栓预防率：成功还是失败？
J Thromb Haemost. 2007 Aug;5(8):1610-6. doi: 10.1111/j.1538-7836.2007.02650.x.
6
Preventing pulmonary embolism and deep vein thrombosis: a 'call to action' for vascular medicine specialists.预防肺栓塞和深静脉血栓形成：对血管医学专家的“行动呼吁”。
J Thromb Haemost. 2007 Aug;5(8):1607-9. doi: 10.1111/j.1538-7836.2007.02651.x.
7
Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy.血栓栓塞是接受门诊化疗的癌症患者死亡的主要原因。
J Thromb Haemost. 2007 Mar;5(3):632-4. doi: 10.1111/j.1538-7836.2007.02374.x.
8
Thromboprophylaxis in medically ill patients at risk for venous thromboembolism.对有静脉血栓栓塞风险的内科疾病患者进行血栓预防。
Am J Health Syst Pharm. 2006 Oct 15;63(20 Suppl 6):S23-9. doi: 10.2146/ajhp060390.
9
Incidence of venous thromboembolism and its effect on survival among patients with common cancers.常见癌症患者静脉血栓栓塞的发生率及其对生存的影响。
Arch Intern Med. 2006 Feb 27;166(4):458-64. doi: 10.1001/archinte.166.4.458.
10
Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial.磺达肝癸钠预防老年急性内科患者静脉血栓栓塞的疗效和安全性：随机安慰剂对照试验
BMJ. 2006 Feb 11;332(7537):325-9. doi: 10.1136/bmj.38733.466748.7C. Epub 2006 Jan 26.
Zotero 插件